Is Bright Eyes the End to Cataract Surgery?
Ethos Endymion or Bright Eyes is a new revolutionary product discovered to give an effective checkmate to the problem of cataract. Since the product was aired in the popular UK television show tagged “Richard and Judy Television Show” the popularity of the drugs has increased tremendously. The increase in the popularity is not because of the way the product was described at that television show but because of what it offers as the most effective substitute to cataract operation. The brain behind the product, Ethos has made it known that the Bright Eyes could mean an end to cataract surgical operations. The product was manufactured from the neuropeptide L-Carnosine a natural occurring substance. This is both a super antioxidant as well as anti-glycating agent. The drug penetrates deep into the eye and protects the lipid tissues from the damaging effects of glycosylation a problem that is related with eye degenerative diseases.
Cataract is a global health concern. It is one of the dreadful diseases confronting many people in the world, and health experts are concerned on how to bring it under control. At last count it was reported that about 17 million people are globally going blind as a result of cataract, with 28,000 fresh cases being reported on daily basis. It was shown that not fewer than 25% of the people who fall within the age range of 65 and 50% of the elderly people whose ages are above 80 are having serious eye impairment problem as a result of cataracts. Report had shown that at the same period in the United Kingdom alone that there are more than 500,000 patients queuing up for cataract operation; the figure for the other parts of Europe is alarming. At a particular United Kingdom hospital it was reported that 250 to 300 cataracts operations are performed every week. Addressing the backlog becomes such challenging that experts were flown in from other countries to meet with the increasing demand of cataract surgical operations.
The clinical trials for the Bright Eyes were carried out in China and Russia. In one such trial did on 96 patients who suffer from varying degrees of cataract eye problem the outcome of the trial was a resounding success for the new drug as there was 100% cure for those patients who were suffering primary senile cataract. For those sufferings from mature senile cataract disease the trial returned a recovery percentage of 80 for the six months the trials were carried out. The result was also encouraging for the patients with other forms of cataract disease. Another clinical trial conducted for cataract patients also showed an improvement rate of 41.5% to 100% within the trial period of 6 months. The result of another trial 24 months later showed much improvement in the effectiveness of the Bright Eyes as total cure to cataract. One may think that because of the effectiveness of the eye drop that the cost may be beyond reach. That is not the case; a box of Bright Eyes goes for about $100 (that is £50 or €75). A box contains 2 x 5ml bottles which is equivalent to 30 days supply that is if one applies two drops a day to each of the eyes. With more and more people acquiring more knowledge on positive effects the usage of the drugs will multiply tremendously. It is very inexpensive when is compared with the cost of a cataract operation which is put at over $3,500 (or £2,000, €3,000) just for one eye, and over $6,500 (or £3,500 or €5,000) for both eyes..
